How rock-bottom prices drive shortages of generic drugs used in hospitals
Rena Conti, TPRI Faculty Director, quoted in NPR, December 28, 2023.
Tag: Rena Conti
Critical Technology Assessment for biopharmaceuticals: Insights from a one-year pilot
Marta Wosińska and Rena Conti, TPRI Faculty Director, article
“Critical Technology Assessment for biopharmaceuticals: Insights from a one-year pilot” Brookings Institution, November 1, 2023.
The estimated annual financial impact of gene therapy in the United States
By Chi Heem Wong, Dexin Li, Nina Wang, Jonathan Gruber, Andrew W. Lo & Rena M. Conti
Gene therapy is a new class of medical treatment that alters part of a patient’s genome through the replacement, deletion, or insertion of genetic material.
People are underestimating the significance of drug pricing provisions in Inflation Reduction Act
Rena Conti, Leslie Dach and Richard Frank, Opinion Article The Hill, October 6, 2023.
Bipartisan battle over prescription intermediaries heats up
Rena Conti, TPRI Faculty Director, quoted in The Hill, 09/28/23
Second House Oversight Hearing Shines a Harsh Light on PBM Practices
Rena Conti, TPRI Faculty Director, quoted in Pharmacy Practice News, 09/19/23
Tornado damage to Pfizer factory highlights vulnerabilities of drug supply
Rena Conti, TPRI Faculty Director, quoted in NPR, July 27, 2023
National Network for Critical Technology Assessment
Rena Conti, TPRI’s Faculty Director will lead the Opportunities for Biotechnology to Improve Pharmaceutical Supply Chain Resiliency pilot project (one of six pilot projects) in the National Network for Critical Technology Assessment.The project will systematically assess vulnerabilities in the supply chain of essential medicines and identify opportunities to improve supply chain resiliency. As part of […]
Mark Cuban’s Pharmacy Adds Another Onc Drug: Capecitabine
Rena Conti, TPRI Faculty Director, quoted in Medscape, May 26, 2023.
Humira Rivals Set to Try to Drive Down Cost of Blockbuster Drug
Rena Conti quoted in Bloomberg Law, January 31, 2023.